Literature DB >> 27423528

Primary and Secondary Stroke Prevention in Children With Sickle Cell Disease.

A Kyle Mack, Alexis A Thompson.   

Abstract

Children with sickle cell disease (SCD) have numerous acute and chronic complications, including central nervous system (CNS) disease, which can be debilitating over their life span. Recognition of risk factors for CNS disease and overt CNS disease should be properly identified by primary care providers, including physicians, physician assistants, and nurse practitioners. Here, we discuss an emerging and important early indicator of CNS disease in the form of silent cerebral infarcts and review overt stroke in patients with SCD. We also discuss transcranial Doppler ultrasonography, when and how often transcranial Doppler ultrasounds should be performed, and management of abnormal results. Lastly, we review the clinical data for the management and prevention of silent cerebral infarcts and overt stroke in children with SCD.
Copyright © 2016 National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebral infarct; sickle cell disease; stroke; transcranial Doppler ultrasonography

Mesh:

Substances:

Year:  2016        PMID: 27423528     DOI: 10.1016/j.pedhc.2016.06.005

Source DB:  PubMed          Journal:  J Pediatr Health Care        ISSN: 0891-5245            Impact factor:   1.812


  3 in total

Review 1.  Neurological and Neurosurgical Emergencies in Patients with Hematological Disorders.

Authors:  Martha L Cruz; Shama Farooq; Fernando D Testai
Journal:  Curr Neurol Neurosci Rep       Date:  2017-03       Impact factor: 5.081

Review 2.  Neurologic Complications of Sickle Cell Disease.

Authors:  Shama Farooq; Fernando D Testai
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-28       Impact factor: 5.081

Review 3.  Pediatric Stroke: Overview and Recent Updates.

Authors:  Mary Hollist; Katherine Au; Larry Morgan; Padmashri A Shetty; Riddhi Rane; Abraham Hollist; Angela Amaniampong; Batool F Kirmani
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.